QGEN

Qiagen NV

Price

$42.13

return (12m)

-7.73%

p/e

21.97

p/bv

2.68

DIVIDEND YIELD

5.25%

QGEN price

Qiagen NV

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment QGEN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-1.98%

3 months

20.71%

1 year

-7.73%

2 years

-9.39%

5 years

-22.10%

10 years

61.79%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals QGEN

Valuation

P/E

21.97

Sector 7.89

Industry 7.89

P/BV

2.68

Sector 1.90

Industry 1.90

P/Revenue (PSR)

4.28

Sector 1.84

Industry 1.84

EV/EBITDA

50.99

Sector -306.06

Industry -306.06

EV/EBIT

69.13

Sector -33,681,485.72

Industry -33,681,485.72

P/EBITDA

12.78

Sector -6.34

Industry -6.34

P/EBIT

17.94

Sector -7.33

Industry -7.33

P/Total Assets

1.53

Sector 0.89

Industry 0.89

P/Net Current Assets

-10.28

Sector -2.16

Industry -2.16

P/Working Capital

8.36

Sector -4,990.91

Industry -4,990.91

EPS

1.99

Sector 0.73

Industry 0.73

BVPS

16.30

Sector 10.03

Industry 10.03

Efficiency

Gross Margin

62.20%

Sector 35.34%

Industry 35.34%

EBITDA Margin

36.01%

Sector -7,057,929.62%

Industry -7,057,929.62%

EBIT Margin

26.56%

Sector -187.23%

Industry -187.23%

Operating Margin

24.60%

Sector 4.35%

Industry 4.35%

Net Profit Margins

19.49%

Sector 2.73%

Industry 2.73%

Asset Turnover

0.09

Sector 0.11

Industry 0.11

Profitability

ROE

12.19%

Sector 2.54%

Industry 2.54%

ROA

6.95%

Sector -0.60%

Industry -0.60%

ROIC

9.60%

Sector -115.70%

Industry -115.70%

Dividends

Dividend yield

5.25%

Sector 0.49%

Industry 0.49%

Payout

115.34%

Sector 9.93%

Industry 9.93%

Debt

Current Ratio

2.85

Sector 1.46

Industry 1.46

Net Debt / EBITDA

4.33

Sector -20.13

Industry -20.13

Net Debt / EBIT

5.87

Sector -207,524,790.05

Industry -207,524,790.05

Net Debt / Equity

0.25

Sector -0.77

Industry -0.77

Gross Debt / Equity

0.48

Sector -0.51

Industry -0.51

Equity/Assets

0.57

Sector 0.43

Industry 0.43

Liabilities/Assets

0.43

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

-1.38%

Sector -

Industry -

5Y Earnings CAGR

-4.40%

Sector -

Industry -

Fundamentals QGEN

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Qiagen NV ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$42.13

Fair Value

$27.02

Upside Return potential.

-35.88%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

QGEN Historical Dividends

current DY: 5.25%

5-year average DY: 0.79%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/06/2026	07/14/2026	2.29000000
Dividends	07/01/2025	07/10/2025	0.26315789
Dividends	01/29/2024	01/31/2024	1.47009925
Dividends	01/24/2017	01/25/2017	1.28662656

ABOUT Qiagen NV

Qiagen NV

Average Investor10 user rating

4.0 (4 people)

United States

- year

Founded:

1996

Time since IPO - 30 years

5.500

Employees

Qiagen NV (United States) is listed on the Nasdaq and has a market capitalization of $8.99 billion, with shareholders equity totaling $3.36 billion.

The company employs approximately 5.500 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Qiagen NV reported $2.10 billion in revenue, generating net income of $409.31 million.

Key financial metrics include a P/E ratio of 21.97, a price-to-book (P/B) ratio of 2.68, and a trailing twelve-month dividend yield of 5.25%.

The company trades under the ticker QGEN.

Market cap

$8.99 billion

Net worth

$3.36 billion

$3,357,740,000.00

Assets

$5.89 billion

$5,889,200,000.00

Total Shares Outstanding

206.00 million

206,000,000

Average Daily Trading Volume

$3.00 million

$2,995,440.16

Sector

Others

Industry

Others

QGEN

QGEN revenue and profits

Financial Results QGEN

DRAG THE FRAME TO SEE MORE DATA

QGEN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.28 13,40% (12M)

P/E

23.91

2.26%

ROE

14.27%

P/BV

3.41

SHEL - Shell PLC ADR

$95.96 39,58% (12M)

P/E

9.97

3.19%

ROE

14.29%

P/BV

1.42

STLA - Stellantis NV

$5.28 --44,83% (12M)

P/E

-0.63

0.00%

ROE

-35.93%

P/BV

0.23

COR - Cencora Inc.

$320.95 6,80% (12M)

P/E

24.46

0.72%

ROE

81.48%

P/BV

19.93

ALIZY - Allianz SE ADR

$50.91 --10,01% (12M)

P/E

14.43

2.60%

ROE

17.89%

P/BV

2.58

TTE - TotalEnergies SE ADR

$91.24 60,92% (12M)

P/E

7.11

4.58%

ROE

21.42%

P/BV

1.52

NSRGY - Nestle SA ADR

$95.37 7,43% (12M)

P/E

11.62

4.14%

ROE

58.05%

P/BV

6.75

ELV - Elevance Health Inc

$416.54 35,64% (12M)

P/E

19.53

1.73%

ROE

9.84%

P/BV

1.92